Russell Alan J

CIK 00018535291 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001853529

Recent Transactions

50 trades

Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-11-12$21.12/sh−100,000→ 23,400 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-11-12$0.18/sh+100,000→ 123,400 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-11-12−100,000→ 1,147,365 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-08-26−100,000→ 1,247,365 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-26$0.18/sh+100,000→ 123,400 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-26$14.60/sh−100,000→ 23,400 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-08-12+168,750→ 168,750 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12−5,781→ 17,344 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12+28,125→ 28,125 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12$13.39/sh−1,907→ 23,400 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12+5,781→ 25,307 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-02$16.45/sh−1,551→ 18,521 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-01+5,209→ 20,072 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-05-01−5,209→ 0 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-03-07$30.02/sh−200→ 14,863 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-03-07$0.18/sh+200→ 15,063 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-03-07−200→ 1,456,580 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-06$0.18/sh+1,200→ 16,063 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-02-06−1,200→ 1,347,565 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-06$30.13/sh−1,200→ 14,863 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-05$30.02/sh−8,015→ 14,863 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-05$0.18/sh+8,015→ 22,878 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-02-05−8,015→ 1,348,765 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-12-30$0.18/sh+100,000→ 114,863 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-12-30−100,000→ 1,356,780 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-12-30$27.37/sh−100,000→ 14,863 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$29.51/sh−815→ 12,719 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$28.25/sh−74,185→ 13,534 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$0.18/sh+75,000→ 87,719 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-09-20−75,000→ 1,456,780 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-08-12+23,125→ 23,125 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-08-12+138,750→ 138,750 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-02$18.91/sh−1,576→ 7,238 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-01+5,208→ 8,814 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-05-01−5,208→ 5,209 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-12-26$9.33/sh−172,585→ 3,606 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2023-08-17+200,000→ 200,000 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-02$8.90/sh−1,602→ 176,191 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2023-05-01−5,208→ 10,417 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-01+5,208→ 177,793 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2022-08-08+220,000→ 220,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2022-05-01+15,625→ 15,625 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2021-11-30−147,585→ 0 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2021-11-30−25,000→ 130,352 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-30$0.18/sh+147,585→ 147,585 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-30$0.45/sh+25,000→ 172,585 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-15$19.07/sh−441→ 38 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-15$19.61/sh−38→ 0 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-12$19.51/sh−8,562→ 479 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2021-11-11$19.82/sh−15,595→ 12,722 total

Companies

Edgewise Therapeutics, Inc.
Director, Chief Scientific Officer
$EWTX

Recent Filings

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301

View on SEC.gov